347 related articles for article (PubMed ID: 28417421)
1. A review of infectious complications after haploidentical hematopoietic stem cell transplantations.
Atilla E; Atilla PA; Bozdağ SC; Demirer T
Infection; 2017 Aug; 45(4):403-411. PubMed ID: 28417421
[TBL] [Abstract][Full Text] [Related]
2. Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis.
Crocchiolo R; Bramanti S; Vai A; Sarina B; Mineri R; Casari E; Tordato F; Mauro E; Timofeeva I; Lugli E; Mavilio D; Carlo-Stella C; Santoro A; Castagna L
Transpl Infect Dis; 2015 Apr; 17(2):242-9. PubMed ID: 25648539
[TBL] [Abstract][Full Text] [Related]
3. Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
Blaise D; Fürst S; Crocchiolo R; El-Cheikh J; Granata A; Harbi S; Bouabdallah R; Devillier R; Bramanti S; Lemarie C; Picard C; Chabannon C; Weiller PJ; Faucher C; Mohty B; Vey N; Castagna L
Biol Blood Marrow Transplant; 2016 Jan; 22(1):119-24. PubMed ID: 26341397
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study.
Styczynski J; Czyzewski K; Wysocki M; Gryniewicz-Kwiatkowska O; Kolodziejczyk-Gietka A; Salamonowicz M; Hutnik L; Zajac-Spychala O; Zaucha-Prazmo A; Chelmecka-Wiktorczyk L; Siewiera K; Fraczkiewicz J; Malas Z; Tomaszewska R; Irga-Jaworska N; Plonowski M; Ociepa T; Pierlejewski F; Gamrot Z; Urbanek-Dadela A; Gozdzik J; Stolpa W; Dembowska-Baginska B; Perek D; Matysiak M; Wachowiak J; Kowalczyk J; Balwierz W; Kalwak K; Chybicka A; Badowska W; Szczepanski T; Drozynska E; Krawczuk-Rybak M; Urasinski T; Mlynarski W; Woszczyk M; Karolczyk G; Sobol-Milejska G; Gil L;
Clin Microbiol Infect; 2016 Feb; 22(2):179.e1-179.e10. PubMed ID: 26493843
[TBL] [Abstract][Full Text] [Related]
5. Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation.
Srinivasan A; Wang C; Srivastava DK; Burnette K; Shenep JL; Leung W; Hayden RT
Biol Blood Marrow Transplant; 2013 Jan; 19(1):94-101. PubMed ID: 22922523
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation.
Slade M; Goldsmith S; Romee R; DiPersio JF; Dubberke ER; Westervelt P; Uy GL; Lawrence SJ
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 28030755
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
8. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation.
Sun Y; Xu L; Liu D; Zhang X; Han W; Wang Y; Chen H; Chen Y; Wang F; Wang J; Ji Y; Tang F; Liu K; Huang XJ
Clin Microbiol Infect; 2013 Nov; 19(11):1029-34. PubMed ID: 23565830
[TBL] [Abstract][Full Text] [Related]
9. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
10. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
[TBL] [Abstract][Full Text] [Related]
11. A prospective observational study of immune reconstitution following transplantation with post-transplant reduced-dose cyclophosphamide from HLA-haploidentical donors.
Nakamae H; Fujii K; Nanno S; Okamura H; Nakane T; Koh H; Nakashima Y; Nakamae M; Hirose A; Teshima T; Hino M
Transpl Int; 2019 Dec; 32(12):1322-1332. PubMed ID: 31432532
[TBL] [Abstract][Full Text] [Related]
12. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.
Sahin U; Toprak SK; Atilla PA; Atilla E; Demirer T
J Infect Chemother; 2016 Aug; 22(8):505-14. PubMed ID: 27344206
[TBL] [Abstract][Full Text] [Related]
13. Infections diagnosed in the first year after pediatric stem cell transplantation.
Benjamin DK; Miller WC; Bayliff S; Martel L; Alexander KA; Martin PL
Pediatr Infect Dis J; 2002 Mar; 21(3):227-34. PubMed ID: 12005087
[TBL] [Abstract][Full Text] [Related]
14. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Infectious Complications in Children With Acute Lymphoblastic Leukemia Treated With Hematopoietic Stem Cell Transplantation.
Zaucha-Prażmo A; Kowalczyk JR; Drabko K; Czyżewski K; Goździk J; Zając-Spychała O; Wachowiak J; Frączkiewicz J; Gorczyńska E; Kałwak K; Styczyński J
Transplant Proc; 2017 Nov; 49(9):2183-2187. PubMed ID: 29149980
[TBL] [Abstract][Full Text] [Related]
16. [Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].
Nguyen S; Chalandon Y; Lemarie C; Simon S; Masson D; Dhedin N; Suarez F; Renaud B; Charbonnier A; Yafour N; François S; Duléry R; Blaise D; Yakoub-Agha I; Rubio MT
Bull Cancer; 2016 Nov; 103(11S):S229-S242. PubMed ID: 27842860
[TBL] [Abstract][Full Text] [Related]
17. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
Gaballa S; Ge I; El Fakih R; Brammer JE; Kongtim P; Tomuleasa C; Wang SA; Lee D; Petropoulos D; Cao K; Rondon G; Chen J; Hammerstrom A; Lombardi L; Alatrash G; Korbling M; Oran B; Kebriaei P; Ahmed S; Shah N; Rezvani K; Marin D; Bashir Q; Alousi A; Nieto Y; Qazilbash M; Hosing C; Popat U; Shpall EJ; Khouri I; Champlin RE; Ciurea SO
Cancer; 2016 Nov; 122(21):3316-3326. PubMed ID: 27404668
[TBL] [Abstract][Full Text] [Related]
18. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea.
Cho SY; Lee HJ; Lee DG
Korean J Intern Med; 2018 Mar; 33(2):256-276. PubMed ID: 29506345
[TBL] [Abstract][Full Text] [Related]
19. Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Busca A; Locatelli F; Barbui A; Ghisetti V; Cirillo D; Serra R; Audisio E; Falda M
Transpl Infect Dis; 2003 Sep; 5(3):132-9. PubMed ID: 14617301
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.
González-Vicent M; Molina B; Andión M; Sevilla J; Ramirez M; Pérez A; Díaz MA
Eur J Haematol; 2011 Jul; 87(1):46-53. PubMed ID: 21692851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
